{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:50:58Z","timestamp":1790891458847,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"USAMRMC\/TATRC","award":["W81XWH1210538"],"award-info":[{"award-number":["W81XWH1210538"]}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["EY011386"],"award-info":[{"award-number":["EY011386"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"USC Whittier foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.jconrel.2014.11.016","type":"journal-article","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T15:50:48Z","timestamp":1417621848000},"page":"156-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["A thermo-responsive protein treatment for dry eyes"],"prefix":"10.1016","volume":"199","author":[{"given":"Wan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarti","family":"Jashnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhaas R.","family":"Aluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pang-Yu","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Yarber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"McKown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon W.","family":"Laurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F.","family":"Hamm-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Andrew","family":"MacKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2014.11.016_bb0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.preteyeres.2009.04.003","article-title":"Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases","volume":"28","author":"Dartt","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0010","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/OPX.0b013e318181ae73","article-title":"Dry eye and designer ophthalmics","volume":"85","author":"Laurie","year":"2008","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/ICU.0b013e32833a8c15","article-title":"Impact of dry eye disease and treatment on quality of life","volume":"21","author":"Friedman","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0020","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00003226-199811000-00002","article-title":"The pathology of dry eye: the interaction between the ocular surface and lacrimal glands","volume":"17","author":"Stern","year":"1998","journal-title":"Cornea"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0025","first-page":"192","article-title":"Dry eye syndrome","volume":"6","author":"Javadi","year":"2011","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0030","first-page":"1797","article-title":"Emerging treatment options for meibomian gland dysfunction","volume":"7","author":"Qiao","year":"2013","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0035","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ajo.2013.10.019","article-title":"Evaluation of a thermosensitive atelocollagen punctal plug treatment for dry eye disease","volume":"157","author":"Kojima","year":"2014","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/jop.1994.10.17","article-title":"Collagen-based drug delivery and artificial tears","volume":"10","author":"Kaufman","year":"1994","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ajo.2013.11.014","article-title":"The influence of benign essential blepharospasm on dry eye disease and ocular inflammation","volume":"157","author":"Lu","year":"2014","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0050","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1167\/iovs.13-12132","article-title":"Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures","volume":"54","author":"Wei","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0055","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ophtha.2010.12.016","article-title":"Treatment of Sjogren's syndrome-associated dry eye an evidence-based review","volume":"118","author":"Akpek","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0060","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.exer.2008.09.002","article-title":"Lacritin and other new proteins of the lacrimal functional unit","volume":"88","author":"McKown","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.exer.2013.05.020","article-title":"Lacritin and the tear proteome as natural replacement therapy for dry eye","volume":"117","author":"Karnati","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/jmbi.2001.4748","article-title":"cDNA and genomic cloning of lacritin, a novel secretion enhancing factor from the human lacrimal gland","volume":"310","author":"Sanghi","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0075","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1167\/iovs.12-10394","article-title":"Lacritin-induced secretion of tear proteins from cultured monkey lacrimal acinar cells","volume":"54","author":"Fujii","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0080","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1167\/iovs.10-6220","article-title":"Lacritin, a novel human tear glycoprotein, promotes sustained basal tearing and is well tolerated","volume":"52","author":"Samudre","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2014.11.016_bb0085","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1167\/iovs.14-13924","article-title":"Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease","volume":"55","author":"Vijmasi","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0090","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1083\/jcb.200605140","article-title":"Restricted epithelial proliferation by lacritin via PKCalpha-dependent NFAT and mTOR pathways","volume":"174","author":"Wang","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0095","doi-asserted-by":"crossref","first-page":"18146","DOI":"10.1074\/jbc.M112.436584","article-title":"Lacritin rescues stressed epithelia via rapid forkhead box O3 (FOXO3)-associated autophagy that restores metabolism","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0100","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1083\/jcb.200511134","article-title":"Heparanase deglycanation of syndecan-1 is required for binding of the epithelial-restricted prosecretory mitogen lacritin","volume":"174","author":"Ma","year":"2006","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0105","doi-asserted-by":"crossref","first-page":"12090","DOI":"10.1074\/jbc.M112.422717","article-title":"Targeting of heparanase-modified syndecan-1 by prosecretory mitogen lacritin requires conserved core GAGAL plus heparan and chondroitin sulfate as a novel hybrid binding site that enhances selectivity","volume":"288","author":"Zhang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0110","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1167\/iovs.12-11488","article-title":"Tissue transglutaminase is a negative regulator of monomeric lacritin bioactivity","volume":"54","author":"Velez","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.exer.2007.01.025","article-title":"Focus on molecules: lacritin","volume":"86","author":"Ma","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051979","article-title":"Lacrimal proline rich 4 (LPRR4) protein in the tear fluid is a potential biomarker of dry eye syndrome","volume":"7","author":"Aluru","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrd1721","article-title":"The rise and rise of drug delivery","volume":"4","author":"Rosen","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1126\/science.1219657","article-title":"Chemistry. Nanomaterials for drug delivery","volume":"337","author":"Hubbell","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0135","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1021\/bm301558q","article-title":"Switchable elastin-like polypeptides that respond to chemical inducers of dimerization","volume":"14","author":"Dhandhukia","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0140","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/nn403973g","article-title":"A hybrid protein\u2013polymer nanoworm potentiates apoptosis better than a monoclonal antibody","volume":"8","author":"Aluri","year":"2014","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.jconrel.2014.11.016_bb0145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jconrel.2013.05.013","article-title":"Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo","volume":"171","author":"Shi","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0150","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1073\/pnas.1214518110","article-title":"Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose control","volume":"110","author":"Amiram","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0155","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/15100","article-title":"Purification of recombinant proteins by fusion with thermally-responsive polypeptides","volume":"17","author":"Meyer","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0160","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1021\/nl401088b","article-title":"Light-controlled graphene\u2013elastin composite hydrogel actuators","volume":"13","author":"Wang","year":"2013","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0165","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.addr.2010.04.002","article-title":"Applications of elastin-like polypeptides in tissue engineering","volume":"62","author":"Nettles","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0170","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1073\/pnas.1009881108","article-title":"Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds","volume":"108","author":"Koria","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0175","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1021\/nl300630c","article-title":"Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution","volume":"12","author":"Callahan","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0180","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nmat2569","article-title":"Self-assembling chimeric polypeptide\u2013doxorubicin conjugate nanoparticles that abolish tumours after a single injection","volume":"8","author":"MacKay","year":"2009","journal-title":"Nat. Mater."},{"issue":"3","key":"10.1016\/j.jconrel.2014.11.016_bb0185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2013.07.016","article-title":"A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjogren's syndrome","volume":"171","author":"Shah","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2014.04.028","article-title":"Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cells","author":"Wang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0195","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.1039\/C4TB00979G","article-title":"Lacritin-mediated regeneration of the corneal epithelia by protein polymer nanoparticles","volume":"2","author":"Wang","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0200","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1021\/bm901387t","article-title":"Recursive directional ligation by plasmid reconstruction allows rapid and seamless cloning of oligomeric genes","volume":"11","author":"McDaniel","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0205","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1039\/C3PY00537B","article-title":"A quantitative recipe for engineering protein polymer nanoparticles","volume":"5","author":"Janib","year":"2014","journal-title":"Polym. Chem."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0210","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1167\/iovs.11-8567","article-title":"Detection of prosecretory mitogen lacritin in nonprimate tears primarily as a C-terminal-like fragment","volume":"53","author":"Laurie","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"Pt 9","key":"10.1016\/j.jconrel.2014.11.016_bb0215","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1242\/jcs.111.9.1267","article-title":"Microtubules facilitate the stimulated secretion of beta-hexosaminidase in lacrimal acinar cells","volume":"111","author":"da Costa","year":"1998","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0220","doi-asserted-by":"crossref","first-page":"C507","DOI":"10.1152\/ajpcell.00355.2010","article-title":"Rab27b regulates exocytosis of secretory vesicles in acinar epithelial cells from the lacrimal gland","volume":"301","author":"Chiang","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0225","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1167\/iovs.11-8729","article-title":"Tear lacritin levels by age, sex, and time of day in healthy adults","volume":"53","author":"Seifert","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0230","doi-asserted-by":"crossref","first-page":"11299","DOI":"10.1021\/ja4047872","article-title":"Hydration layer coupling and cooperativity in phase behavior of stimulus responsive peptide polymers","volume":"135","author":"Kurzbach","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0235","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1242\/jcs.02573","article-title":"Actin and non-muscle myosin II facilitate apical exocytosis of tear proteins in rabbit lacrimal acinar epithelial cells","volume":"118","author":"Jerdeva","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0240","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.exer.2010.06.008","article-title":"Focus on molecules: syndecan-1","volume":"93","author":"Zhang","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0245","first-page":"49","article-title":"The NOD mouse as a model of type I diabetes","volume":"8","author":"Tochino","year":"1987","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0250","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1073\/pnas.94.11.5767","article-title":"Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjogren syndrome","volume":"94","author":"Robinson","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0255","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1172\/JCI118879","article-title":"Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55","volume":"98","author":"Hunger","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0260","first-page":"125","article-title":"Histologic examination of the NOD-mouse lacrimal glands, a potential model for idiopathic autoimmune dacryoadenitis in Sjogren's syndrome","volume":"46","author":"Moore","year":"1996","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0265","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/978-1-4615-2417-5_105","article-title":"Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjogren's syndrome","volume":"350","author":"Humphreys-Beher","year":"1994","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0270","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1006\/exer.1999.0715","article-title":"Impact of gender on exocrine gland inflammation in mouse models of Sjogren's syndrome","volume":"69","author":"Toda","year":"1999","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0275","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.exer.2009.10.008","article-title":"Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjogren's syndrome-like exocrinopathy","volume":"90","author":"Schenke-Layland","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0280","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nbt0410-311","article-title":"Biotech in a blink","volume":"28","author":"Garber","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0285","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrd1106","article-title":"Ophthalmic drug discovery","volume":"2","author":"Clark","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0290","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/clpt.2008.297","article-title":"Ophthalmic drug delivery: development and regulatory considerations","volume":"85","author":"Novack","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0295","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd2399","article-title":"Protein therapeutics: a summary and pharmacological classification","volume":"7","author":"Leader","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0300","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2010.01.032","article-title":"Injectable intratumoral depot of thermally responsive polypeptide\u2013radionuclide conjugates delays tumor progression in a mouse model","volume":"144","author":"Liu","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0305","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2013.07.021","article-title":"A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection","volume":"172","author":"Amiram","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0310","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/cr000033x","article-title":"Serine protease mechanism and specificity","volume":"102","author":"Hedstrom","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0315","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1073\/pnas.87.17.6659","article-title":"Substrate specificity of trypsin investigated by using a genetic selection","volume":"87","author":"Evnin","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0320","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00018-005-5160-x","article-title":"The catalytic triad of serine peptidases","volume":"62","author":"Polgar","year":"2005","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0325","doi-asserted-by":"crossref","first-page":"e50300","DOI":"10.1371\/journal.pone.0050300","article-title":"PROSPER: an integrated feature-based tool for predicting protease substrate cleavage sites","volume":"7","author":"Song","year":"2012","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.jconrel.2014.11.016_bb0330","doi-asserted-by":"crossref","first-page":"22172","DOI":"10.1074\/jbc.M114.570143","article-title":"A cleavage potentiated fragment of tear lacritin is bactericidal","volume":"289","author":"McKown","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0335","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1021\/ac00220a025","article-title":"Recognition of trypsin autolysis products by high-performance liquid chromatography and mass spectrometry","volume":"62","author":"Vestling","year":"1990","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0340","first-page":"269","article-title":"Calcium\u2014an \u201call-round player\u201d in the cornea","volume":"3","author":"Kraus","year":"2001","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0345","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/02713688908995762","article-title":"Signal transduction and control of lacrimal gland protein secretion: a review","volume":"8","author":"Dartt","year":"1989","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0350","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nmat2130","article-title":"Polymer therapeutics: reservoir drugs","volume":"7","author":"Setton","year":"2008","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2014.11.016_bb0355","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1063273","article-title":"Drug delivery. Drugs on target","volume":"293","author":"Langer","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0360","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jconrel.2013.08.024","article-title":"PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release","volume":"172","author":"Parent","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.11.016_bb0365","doi-asserted-by":"crossref","first-page":"21444","DOI":"10.1073\/pnas.1217972110","article-title":"Painting blood vessels and atherosclerotic plaques with an adhesive drug depot","volume":"109","author":"Kastrup","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914007640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914007640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T08:20:56Z","timestamp":1690705256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914007640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":73,"alternative-id":["S0168365914007640"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.11.016","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A thermo-responsive protein treatment for dry eyes","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}